Anavex Completes Patient Enrollment for Phase 2a Alzheimer’s Trial Ahead of Schedule

[GlobeNewswire] – NEW YORK, Sept. 28, 2015– Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’ s disease, other central nervous system diseases, pain, … http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/anavex-completes-patient-enrollment-phase-110000635.html